Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for <i>Helicobacter pylori</i> Therapy
<i>Helicobacter pylori</i> is a class I carcinogen that infects more than 100 million individuals in the United States. Antimicrobial therapy for <i>H. pylori</i> has typically been prescribed empirically rather than based on susceptibility testing. Until recently, therapeuti...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-02-01
|
| Series: | Pharmacoepidemiology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-0618/3/1/6 |